These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 37939386)

  • 1. FASTDock: A Pipeline for Allosteric Drug Discovery.
    Ahmed F; Brooks CL
    J Chem Inf Model; 2023 Nov; 63(22):7219-7227. PubMed ID: 37939386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allosteric Methods and Their Applications: Facilitating the Discovery of Allosteric Drugs and the Investigation of Allosteric Mechanisms.
    Lu S; Shen Q; Zhang J
    Acc Chem Res; 2019 Feb; 52(2):492-500. PubMed ID: 30688063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging paradigms in GPCR allostery: implications for drug discovery.
    Wootten D; Christopoulos A; Sexton PM
    Nat Rev Drug Discov; 2013 Aug; 12(8):630-44. PubMed ID: 23903222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Harnessing allostery: a novel approach to drug discovery.
    Lu S; Li S; Zhang J
    Med Res Rev; 2014 Nov; 34(6):1242-85. PubMed ID: 24827416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Harnessing the druggability at orthosteric and allosteric sites of PD-1 for small molecule discovery by an integrated in silico pipeline.
    Mittal L; Tonk RK; Awasthi A; Asthana S
    Comput Biol Chem; 2023 Dec; 107():107965. PubMed ID: 37826990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computational Tools for Allosteric Drug Discovery: Site Identification and Focus Library Design.
    Huang W; Nussinov R; Zhang J
    Methods Mol Biol; 2017; 1529():439-446. PubMed ID: 27914066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AlloFinder: a strategy for allosteric modulator discovery and allosterome analyses.
    Huang M; Song K; Liu X; Lu S; Shen Q; Wang R; Gao J; Hong Y; Li Q; Ni D; Xu J; Chen G; Zhang J
    Nucleic Acids Res; 2018 Jul; 46(W1):W451-W458. PubMed ID: 29757429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leveraging allostery to improve G protein-coupled receptor (GPCR)-directed therapeutics: cannabinoid receptor 1 as discovery target.
    Janero DR; Thakur GA
    Expert Opin Drug Discov; 2016 Dec; 11(12):1223-1237. PubMed ID: 27712124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opportunities and Challenges in the Discovery of Allosteric Modulators of GPCRs.
    Bartuzi D; Kaczor AA; Matosiuk D
    Methods Mol Biol; 2018; 1705():297-319. PubMed ID: 29188568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allosteric modulation of GPCRs: From structural insights to in silico drug discovery.
    Persechino M; Hedderich JB; Kolb P; Hilger D
    Pharmacol Ther; 2022 Sep; 237():108242. PubMed ID: 35863587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in NMR Methods to Identify Allosteric Sites and Allosteric Ligands.
    Abdelkarim H; Hitchinson B; Banerjee A; Gaponenko V
    Adv Exp Med Biol; 2019; 1163():171-186. PubMed ID: 31707704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ASD2023: towards the integrating landscapes of allosteric knowledgebase.
    He J; Liu X; Zhu C; Zha J; Li Q; Zhao M; Wei J; Li M; Wu C; Wang J; Jiao Y; Ning S; Zhou J; Hong Y; Liu Y; He H; Zhang M; Chen F; Li Y; He X; Wu J; Lu S; Song K; Lu X; Zhang J
    Nucleic Acids Res; 2024 Jan; 52(D1):D376-D383. PubMed ID: 37870448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting the endocannabinoid system: Structural determinants and molecular mechanism of allosteric modulation.
    Yuan J; Yang B; Hou G; Xie XQ; Feng Z
    Drug Discov Today; 2023 Jul; 28(7):103615. PubMed ID: 37172889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploiting protein flexibility to predict the location of allosteric sites.
    Panjkovich A; Daura X
    BMC Bioinformatics; 2012 Oct; 13():273. PubMed ID: 23095452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unmasking allosteric-binding sites: novel targets for GPCR drug discovery.
    Casadó-Anguera V; Casadó V
    Expert Opin Drug Discov; 2022 Aug; 17(8):897-923. PubMed ID: 35649692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allosteric small molecule modulators of nuclear receptors.
    Meijer FA; Leijten-van de Gevel IA; de Vries RMJM; Brunsveld L
    Mol Cell Endocrinol; 2019 Apr; 485():20-34. PubMed ID: 30703487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Research progress of indole-fused derivatives as allosteric modulators: Opportunities for drug development.
    Luo ML; Zhao Q; He XH; Xie X; Zhu HP; You FM; Peng C; Zhan G; Huang W
    Biomed Pharmacother; 2023 Jun; 162():114574. PubMed ID: 36996677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allostery at opioid receptors: modulation with small molecule ligands.
    Livingston KE; Traynor JR
    Br J Pharmacol; 2018 Jul; 175(14):2846-2856. PubMed ID: 28419415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GPCR drug discovery-moving beyond the orthosteric to the allosteric domain.
    Felder CC
    Adv Pharmacol; 2019; 86():1-20. PubMed ID: 31378249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strategies for the identification of allosteric modulators of G-protein-coupled receptors.
    Burford NT; Watson J; Bertekap R; Alt A
    Biochem Pharmacol; 2011 Mar; 81(6):691-702. PubMed ID: 21184747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.